Skip to main content

Advertisement

SpringerLink
Log in

Receptor imaging in breast carcinoma: future prospects

  • Editorial
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cell-to-cell signalling: hormones and receptors. In:. Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell J, eds. Molecular biology. New York: Scientifica American Books; 1995:850-922.

  2. Jardines L, Berger D. Integration of molecular biology into prognostic parameters for breast carcinoma. In: Bland KI, Copeland EM III, eds. The breast, comprehensive management of benign and malignant disease. Philadelphia: Saunders; 1998:435–456.

    Google Scholar 

  3. Gugger M, Reubi JC. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol 1999; 155:2067–2076.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Van Eijck CH, Kwekkeboom DJ, Krenning EP. Somatostatin receptors and breast cancer. Q J Nucl Med 1998; 42:18–25.

    PubMed  Google Scholar 

  5. Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumours and their tissues of origin. Cancer Res 2000; 60:3105–3112.

    CAS  PubMed  Google Scholar 

  6. Bhardwaj B, Klassen J, Cosette N, Sterns E, Tuck A, Deeley R, Sengupta S, Elliott B. Localization of platelet-derived growth factor beta receptor expression in the periepithelial stroma of human breast carcinoma. Clin Cancer Res 1996; 2:773–782.

    CAS  PubMed  Google Scholar 

  7. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995; 26:86–91.

    Article  CAS  PubMed  Google Scholar 

  8. Papa V, Costantino A, Belfiore A. Insulin receptor, what role in breast cancer? TEM 1997; 8:306–312.

    CAS  PubMed  Google Scholar 

  9. Guerin M, Gabiollot M, Mathieu MC, et al. Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory breast cancer and non-inflammatory breast cancer: prognostic significance. Int J Cancer 1989; 43:201–208.

    Article  CAS  PubMed  Google Scholar 

  10. Penault-Llorca F, Bertucci F, Adelaide J, et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 1195; 61:170–176.

    Article  Google Scholar 

  11. Dhingra K, Sahin A, Emami K, Hortobagyi GN, Estrov Z. Expression of leukemia inhibitory factor and its receptor in breast cancer, a potential autocrine and paracrine growth regulatory mechanism. Breast Cancer Res Treat 1998; 48:165–174.

    Article  CAS  PubMed  Google Scholar 

  12. Ridings J, Macardle PJ, Byard RW, Skinner J, Zoal H. Cytokine receptor expression by solid tumours. Ther Immunol 1995; 2:67–76.

    CAS  PubMed  Google Scholar 

  13. Clark GM. Should selection of adjuvant chemotherapy for patients with breast cancer be based on erbB-2 status? J Natl Cancer Inst 1998; 90:1320–1321.

    Article  CAS  PubMed  Google Scholar 

  14. Thor AD, Berry DA, Budman DR, et al. erbB-2, p53, and the efficacy of adjuvant therapy in lymph node positive breast cancer. J Natl Cancer Inst 1998; 90:1346–1360.

    Article  CAS  PubMed  Google Scholar 

  15. Archer CD, Ellis PA, Dowsett M, et al. C-erbB-2 positivity in primary correlates with poor apoptosis response to chemotherapy in primary breast cancer. Breast Cancer Res Treat 1998; 50:237(A).

    Google Scholar 

  16. Bianco AR, DeLaurentiis M, Carlomagno C, et al. 20 year update of the Naples GUN trial of adjuvant breast cancer therapy: evidence of interaction between c-erbB-2 expression and tamoxifen efficacy. Proc Annu Meet Am Soc Clin Oncol 1998; 17:97(A).

    Google Scholar 

  17. Neskovic KZ, Nicolic-Vukosavljevic D, Branovic-Magic M, et al. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease. J Exp Clin Cancer Res 1999; 18:347–355.

    Google Scholar 

  18. Lawrence DS, Niu J. Protein kinase inhibitors. Pharmacol Ther 1998; 77:81–114.

    Article  CAS  PubMed  Google Scholar 

  19. Levitzki A. Targeting signal transduction for disease therapy. Med Oncol 1997; 14:83–89.

    Article  CAS  PubMed  Google Scholar 

  20. Levitzki A, Gazit A. Tyrosine kinase inhibitors: an approach to drug development. Science 1995; 267:1782–1788.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, Ghent University Hospital, De Pintelaan 185, Gent, 9000, Belgium

    Christophe Van de Wiele & Rudi Andre Dierckx

  2. Division of Medical Oncology, Ghent University Hospital, Belgium

    Simon Van Belle

  3. Department of Radiopharmacy, Ghent University, Belgium

    Guido Sleghers

Authors
  1. Christophe Van de Wiele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simon Van Belle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guido Sleghers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rudi Andre Dierckx
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van de Wiele, C., Van Belle, S., Sleghers, G. et al. Receptor imaging in breast carcinoma: future prospects. Eur J Nucl Med 28, 675–679 (2001). https://doi.org/10.1007/s002590000432

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590000432

Search

Navigation